These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22320004)

  • 1. Is there still a place for gene patents in Australia? Implications of recent United States and European case law.
    Ridley A; Nicol D
    J Law Med; 2011 Dec; 19(2):282-99. PubMed ID: 22320004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do patents impede the provision of genetic tests in Australia?
    Nicol D; Liddicoat J
    Aust Health Rev; 2013 Jun; 37(3):281-5. PubMed ID: 23702081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The European opposition against the BRCA gene patents.
    Matthijs G
    Fam Cancer; 2006; 5(1):95-102. PubMed ID: 16528613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Israeli doctors want to stop European patent for genetic test.
    Siegel-Itzkovich J
    BMJ; 2005 Jul; 331(7507):8. PubMed ID: 15994669
    [No Abstract]   [Full Text] [Related]  

  • 5. The continuing saga of patents and non-invasive prenatal testing.
    Hawkins N; Nicol D; Chandrasekharan S; Cook-Deegan R
    Prenat Diagn; 2019 May; 39(6):441-447. PubMed ID: 30900262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myriad and the mass media: the covering of a gene patent controversy.
    Caulfield T; Bubela T; Murdoch CJ
    Genet Med; 2007 Dec; 9(12):850-5. PubMed ID: 18091435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic testing of genetic disorders: limiting the scope of patent claims through disclosure requirements.
    Abbot J
    J Law Med; 2006 Aug; 14(1):110-26. PubMed ID: 16937785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoding gene patents in Australia.
    Denley A; Cherry J
    Cold Spring Harb Perspect Med; 2014 Oct; 5(1):a020909. PubMed ID: 25280901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supreme Court ruling broadens BRCA testing options.
    Azvolinsky A
    J Natl Cancer Inst; 2013 Nov; 105(22):1671-2. PubMed ID: 24198329
    [No Abstract]   [Full Text] [Related]  

  • 10. European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy.
    Paradise J
    Food Drug Law J; 2004; 59(1):133-54. PubMed ID: 15190928
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene and genetic diagnostic method patent claims: a comparison under current European and US patent law.
    Huys I; Van Overwalle G; Matthijs G
    Eur J Hum Genet; 2011 Oct; 19(10):1104-7. PubMed ID: 21654725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Revocation of the BRCA1 patents by the European Office of Patents: a victory over a rights abuse].
    Stoppa-Lyonnet D; Lenoir G
    Bull Cancer; 2005 Apr; 92(4):410-1. PubMed ID: 15888396
    [No Abstract]   [Full Text] [Related]  

  • 13. Patents on breast cancer genes are illegal and stymie research, say scientists.
    Lenzer J
    BMJ; 2009 Nov; 339():b4899. PubMed ID: 19920010
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic testing, ethical concerns, and the role of patent law.
    Caulfield TA; Gold ER
    Clin Genet; 2000 May; 57(5):370-5. PubMed ID: 10852371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. History of a gene patent: tracing the development and application of commercial BRCA testing.
    Williams-Jones B
    Health Law J; 2002; 10():123-46. PubMed ID: 14748275
    [No Abstract]   [Full Text] [Related]  

  • 16. Patent first, ask questions later: morality and biotechnology in patent law.
    Bagley MA
    William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data disclosure crucial after DNA patent verdict.
    de Costa A
    Science; 2013 Aug; 341(6149):959. PubMed ID: 23990544
    [No Abstract]   [Full Text] [Related]  

  • 18. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.
    Bergin C
    Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Divergence in Gene Patenting.
    Nicol D; Dreyfuss RC; Gold ER; Li W; Liddicoat J; Van Overwalle G
    Annu Rev Genomics Hum Genet; 2019 Aug; 20():519-541. PubMed ID: 30786226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patenting genetic diagnostic methods: NGS, GWAS, SNPs and patents.
    Lawson C
    J Law Med; 2015 Jun; 22(4):846-63. PubMed ID: 26349382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.